Abstract Glaucoma is one of the leading causes of blindness in developed countries and is mainly attributable to the apoptosis of retinal ganglion cells (RGCs). Although several diagnostic tools have been developed to detect and monitor this disease, none has the requisite sensitivity to identify it at a preclinical stage or to perceive small changes in retinal health over short periods. Specifically, irreversible visual changes occur before neuronal damage is discovered. The most widely accepted in vitro assay for apoptotic cells involves the use of fluorescent annexin A5. The radiolabelling of this marker makes it possible to assess, in vivo and non-invasively, various diseases in which the apoptotic process is pivotal, such as myocardial infarction or tumour response to chemotherapy. Recently, a new technique has been developed to visualise directly individual RGCs undergoing apoptosis in the living eye. This DARC (detection of apoptosing retinal cells) technology uses fluorescently labelled annexin A5 to bind apoptosing retinal neurons and confocal scanning laser ophthalmoscopy to detect the marked dying cells. Based on experimental models, DARC has been suggested to offer a direct and quantitative assessment of the retinal condition of patients. A Phase I clinical trial in glaucoma patients is scheduled to start shortly. This technology has the potential to pre-empt the diagnosis of glaucoma prior to visual deterioration, to provide an accurate numeric evaluation highlighting even small retinal changes and to allow the rapid judgement of the efficacy of both current and new therapeutic strategies.
myocardial infarction1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Myocardial_infarction 

non-invasively                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Invasiveness_of_surgical_procedures

diagnosis                     0.9659242652843265^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Diagnosis             

glaucoma                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Glaucoma              

technology                    0.999998877987484^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Technology            

glaucoma                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Glaucoma              

confocal                      0.9898480238416203^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Confocal_microscopy   

eye                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Human_eye             

preclinical                   0.9999999999988631^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Clinical_trial        

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

neuronal                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neuron                

quantitative                  0.8960187562663252^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Level_of_measurement  

apoptosis                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Apoptosis             

Glaucoma                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Glaucoma              

sensitivity                   0.9999999999961346^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Sensitivity_and_specificity

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

annexin A5                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Annexin_A5            

chemotherapy                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Chemotherapy          

blindness                     0.9979762514941931^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blind_experiment      

technology                    0.999998877987484^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Technology            

assay                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Assay                 

health                        0.9288522323023282^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Health                

Phase I clinical trial        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Clinical_trial        

retinal ganglion cells        0.9999737592982496^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Retinal_ganglion_cell 

apoptotic cells               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Apoptosis             

apoptosis                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Apoptosis             

neurons                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neuron                

cells                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_(biology)        

tumour                        0.999999994515747^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Tumor                 

apoptotic                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Apoptosis             

annexin A5                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Annexin_A5            

fluorescently                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fluorescence          

efficacy                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Efficacy              

radiolabelling                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Isotopic_labeling     

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

scanning laser ophthalmoscopy 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Scanning_laser_ophthalmoscopy

retinal cells                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

disease                       0.9566140407107423^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

fluorescent                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fluorescence          

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

developed countries           0.9999999985127488^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Developed_country     

